Application of Epigenetics in the Study of Diagnosis and Treatment of Coronary Artery Disease

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OCH-12002349

Enrollment

Unknown

Registered

2012-07-12

Start date

2011-10-26

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary artery disease

Interventions

Patients:NA

control:NA

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. acute myocardial infarction: (Circulation 2007; 116; 2634-2653); 2. unstable angina: (Circulation 2007; 116: e148-e304) 3. stable angina: (chinese Journal of Cardiology )

Exclusion criteria

Exclusion criteria: The patients with ongoing inflammatory, a history of severe hepatic, renal dysfunction, autoimmune disease, malignant disease and leukopenia were excluded.

Design outcomes

Primary

Measure	Time frame
microRNA;Lp-PLA2;MMP;DNA methylation;	—

Countries

China

Contacts

Public ContactHong Chen

chenhongbj@medmail.com.cn+86 010 88325349

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 10, 2026